Belviq Breast Cancer Case Survives Dismissal Motion in Ill. Federal Court



DOCUMENTS
  • Order


EAST ST. LOUIS, Ill. — An Illinois federal judge has refused to dismiss an action in which a woman alleges the weight loss drug Belviq caused her breast cancer, ruling she adequately pled it was unreasonably dangerous in design and that defendants knew or should have known of its risks, yet concealed them from her doctor.

On Nov. 29, Judge Staci M. Yandle of the U.S. District Court for the Southern District of Illinois further found plaintiff and her husband adequately pled breach of warranty, fraudulent misrepresentation and concealment, and negligent misrepresentation.

Sharon Govan took Belviq between 2014 and 2020 …

FIRM NAMES
  • Schlichter Bogard & Denton
  • Sidley Austin
  • Thompson Coburn LLP
  • Tucker Ellis





UPCOMING CONFERENCES




HarrisMartin's Camp Lejeune Litigation Conference: Navigating the Complexities - Where Do We Go From Here?

December 08, 2022 - New York, NY
InterContinental® New York Times Square

MORE DETAILS



HarrisMartin's MDL Conference: Navigating Current Mass Tort Litigation

November 30, 2022 - New York, NY
The Knickerbocker

MORE DETAILS